Pelodis Tablet 10 mg (Memantine Hydrochloride)

Adult dose

Administer orally once daily at the same time every day. If necessary, it may be administered twice daily. Dosage increases should be made weekly by 5 mg for the first 3 weeks. - First week (days 1-7): Administer 5 mg once daily - Second week (days 8-14): Administer 10 mg once daily - Third week (days 15-21): Administer 15 mg once daily - From the fourth week: Administer 20 mg once daily The recommended maintenance dose is 20 mg once daily.

This medication should not be administered to patients with phenylketonuria. As the artificial sweetener aspartame contained in this medication is broken down into phenylalanine in the body, it may pose a risk to individuals with hereditary diseases that restrict phenylalanine intake. Additionally, this medication should not be used in patients with hypersensitivity to it or those with severe liver or kidney dysfunction. In particular, it is contraindicated in cases of significantly reduced kidney function. Since this drug contains lactose, it should not be administered to patients with lactose intolerance or galactose metabolism disorders. Patients with epilepsy or a history of seizures should use this drug with caution, as the risk of side effects may increase when taken in conjunction with certain other medications, and co-administration should be avoided. Patients with heart disease or uncontrolled hypertension should also exercise caution when using this medication. This medication may cause side effects such as dizziness, headache, constipation, drowsiness, and hypertension, so it is advisable to consult healthcare professionals if any unusual symptoms occur. Since there may be interactions with other medications, it is essential to inform healthcare providers about any other medications being taken, particularly avoiding co-administration with NMDA receptor agonists. Women who are pregnant or may become pregnant should carefully weigh the risks and benefits of using this medication, and it is advisable to discontinue breastfeeding if nursing. This medication has not been confirmed to be safe and effective for children under 18 years of age; thus, it is recommended not to use it in this population. In the case of overdose, symptoms may include central nervous system symptoms or gastrointestinal symptoms, and immediate medical attention should be sought. This medication may affect the patient's reaction speed and concentration, so caution is needed when driving or operating machinery. Finally, store this medication out of reach of children, and avoid transferring it to other containers.

Serious side effects

• Seizures
• psychotic reactions
• hallucinations
• heart failure
• venous thrombosis/thromboembolism
• dyspnea
• pancreatitis
• hepatitis

Mild side effects

• Dizziness
• headache
• constipation
• drowsiness
• hypertension
• fungal infections
• drug hypersensitivity reactions
• confusion
• hallucinations
• psychotic reactions

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, preferably at a cool temperature below 30 degrees Celsius. Storing it this way helps maintain its effectiveness.

Appearance

Flat round orally disintegrating tablet with bright pink speckled patterns and rounded edges

Package unit

30 tablets/PTP [15 tablets/PTP x 2], 90 tablets/PTP [15 tablets/PTP x 6]